english french german greek italian lithuanian russian serbian spanish
Inicio arrow In Brief arrow Head of BioEthics InterGroup, MEP Peter Liese : "Embryonic stem cell research reaching its END" !?

Head of BioEthics InterGroup, MEP Peter Liese : "Embryonic stem cell research reaching its END" !?

Escrito por ACM
17.11.11

 human_embryon_400

"Pioneers" of embryonic stem cell research halt clinical trials => Embryonic stem cell research has reached its end, says Peter Liese : Consequences for EU research policy = Focus should be laid on adult stem cell research" 


The US-company Geron has announced to halt its clinical trials with embryonic stem cells. The company has invested millions of dollars over the past years in this kind of research and started the first trial with human embryonic stem cells one year ago. They now announced to stop it and concentrate on their core business, which is cancer research. The announcement of the clinical trial last year had been celebrated as a big breakthrough in science, and the company has invested a lot to convince the US-authority FDA  to approve the trial. The official justification for the halt is that the company lacks money, but independent observers from all over the world see the decision as a prove for the thesis that embryonic stem cells are not the breakthrough- technology that is seemed to be."

- "After ten years of hype, the supporters of embryonic stem cell research finally have to face reality. If even the "pioneers" of embryonic stem cell research cannot generate funds for their trials, it is clear that the belief in this kind of research is gone", said Peter Liese, medical doctor and spokesman on health of the biggest political group in the European Parliament (EPP- Christian Democrats).

- "The latest development demands also consequences for the EU research policy. The halt of the clinical trial with embryonic stem cells has clearly shown that research on embryonic stem cells does not bring added value for the patients. We should therefore not finance it with European public money. Our effort should concentrate on ethically unchallenging alternatives like adult stem cells and stem cells from the umbilical cord. These alternatives have been successfully used in hundreds of clinical trials for more than 70 diseases".

pieter_liese


+ Also the decision of the European Court of Justice in October demands a policy change in Europe. The Court has decided that human embryonic stem cells can not be patented in Europe, and in the justification, the Court referred to human dignity. "If a technology cannot be patented in Europe, it makes no sense to support it with European money. The Commission in its research programs even demands scientists to patent their innovations. It is not useful to do research in Europe and leave the commercial exploitation to other parts of the world", said Liese.

Current drafts of the new Commission research and innovation program Horizon 2020 however indicate a different direction. The Commission obviously intents to finance not only research with human embryonic stem cells but also the derivation of the stem cells with includes the destruction of the embryo. Under the current 7th Research Framework Program research which implies the destruction of human embryos is not funded.

- "I'm confident that the new developments, including the Court case and the announcement of Geron, will convince the European Commission that the future lies in the alternatives and we should not waste European tax payer's money for a technology that is very much disputed, prohibited in some Member States and obviously not successful", Liese said.  

human_embryon_red__gold_ok_dim 

Multi-lingual Interface

Statistics

Visitantes: 56785129

Archive

Login Form

Syndicate

RSS 0.91
RSS 1.0
RSS 2.0
ATOM 0.3
OPML

Other Menu

 

 dsc00905_400

    UK Prime Minister, Gordon Brownn's promise to French President Sarkozy that Great Britain will proceed to Lisbon Treaty's ratification was certainly fuelled further by MEPs' warning, meanwhile in Strasbourg, that all Enlargement stops until EU can have efficient Institutions for more than 27 member Countries.    

    EU Parliament's President, German MEP Hans Gert Poettering, formally announced this position, after consulting all Political Groups' Chairmen, Monday in Strasbourg, and most MEPs made the point crystal clear during Plenary Debates on Wednesday.   

     Thus, from Thursday, UK's House of Commons, at Westminster, gave its "Green Light" to Lisbon Treaty's ratification, which was completed later-on, after ovecoming some last minute attempts to block the process.

    - In only 3 other Member Countries we feel some "hesitations" : Poland, Czech Republic and Cyprus", said, meanwhile, EU Chairman-in-office, Slovenian Foreign Minister, Dr. Dimitri Ruppel, speaking to EU Parliament's Foreign Affairs Committee in Strasbourg, However, "I didn't hear any explicit refusal", he carefully added.

    Rupel's fears were later bellied in Cyprus' case, where a wide majority of political parties confirmed their support to the EU Treaty, but fears were confirmed in Poland's case, while Czechs said they waited for their Constitutional Court to pronounce itself.

    A paradox is that the Polish President Lech Kaczynski, who reportedly expressed concerns about Lisbon Treaty, had personally signed himself its blueprint, while, on the contrary, Cyprus' new President, Christofias, despite its own party's opposal, declared that he'll respect the signature of his precedessor, former President Tassos Papadopoulos, in favor of EU Treaty.

    But, "all that noise is a misinterpretations by some Western Media : Poland will ratify the EU Treaty, and even earlier than some other Member Countries", declared to "EuroFora", in a surprisingly optimistic tone, the Polish Chairman of EU Parliament's Foreign Affairs Committee, Jacek Saryuswolski...

Polls

2009 EU Elections were won by Parties against Technocracy and Turkey's controversial EU bid, while the 1999-2004 Majority Abstention trend decelerated. What should be done in 2009-2014 ?

Mostrados

SMF Recent Topics SA

Copyright (c) 2007-2009 EIW/SENAS - EuroFora.net. All rights reserved. ISSN 1969-6361.
Powered by Elxis - Open Source CMS.